ADVM Similar Chart Price Prediction
The price of ADVM is predicted to go up 1.56%, based on the high correlation periods with BNJ. The similarity of these two price pattern on the periods is 94.08%.
ADVM
BNJ
Up: 1.56%Similarity: 94.08%
ADVM Revenue Forecast
ADVM EPS Forecast
ADVM Analyst's Forecast
Luca Issi
RBC Capital
Hold
2024-11-05
Price Target
$12 → $10
Upside
+30.04%
RBC Capital analyst Luca Issi lowered the firm's price target on Adverum Biotechnologies to $10 from $12 and keeps a Sector Perform rating on the shares after its Q3 results. The company's wet AMD pivotal study start remains on track for the first half of 2025 and a trial design update is expected this quarter, but while the ecent data clearly suggests that lowering the dose and increasing steroid exposure improves the therapeutic index, given prior history and in the context of an increased competitive landscape, the firm remains on the sidelines awaiting further de-risking, the analyst tells investors in a research note.
